fda stops compounding tirzepatide Breaking News: Pharmacies Take the Fight to the Fifth Circuit The Outsourcing Facilities Association (OFA) has filed an appeal challenging the FDA's decision to restrict compounding pharmacies from producing tirzepatide, the FDA says tirzepatide shortage is

In about five months the patent for a key weight loss medication, semaglutide, will lapse in a large number of countries around the world including India, China, Brazil, and Canada although not in the most lucrative markets

doi: 10.1038/s41593-019-0497-x 170 NadataniY.WatanabeT.ShimadaS.OtaniK.TanigawaT.FujiwaraY

a shift in patient consultation and the rising role of facial volume restoration IRVINE, Calif., March 4, 2026 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company, shares new data illustrating how the rapid adoption of Medical Weight Loss (MWL) treatments is changing patient behavior, aesthetic priorities, and treatment demand, particularly as facial volume loss emerges as a leading concern

The dual GIP/GLP-1 mechanism produced robust glycemic control with substantial weight loss, distinguishing it from other diabetes medications

Labs are available but entirely optional